CTBE

NEWS

2022-06-29Yoji Jokura has been appointed as Board Chairman and Chiaki Waki has been appointed as President&CEO. 2022-03-16CTBE was accepted by Johnson & Johnson Innovation (Boston, U.S.A.) as the first startup company in Japan. It was also interviewed and posted by Nikkei Shimbun.2021-11-11CTBE was introduced by "Venture Tanbou" on "Nikkei Biotechnology & Business".2021-10-20CTBE was elected to "J-Startup", the program for supporting the global startup companies sponsored by Japanese governmental organizations (METI, JETRO and NEDO).2021-10-15CTBE raised fund from SUCCESS program of Japan Science and Technology Agency (JST) . The company will accelerate development of the artificial ligament for ACL reconstruction and business development for the US market.2021-10-11CTBE moved to new office with R/D laboratory and manufacturing facility.2021-07-28CTBE presented at Startup Pitch@CIC sponsored by CIC Tokyo and Tokyo University Biodesign and won a prize.2021-05-18CTBE obtained the manufacturing and marketing authorization of the highly controlled medical devices.2020-12-25AMED adopted CTBE to the Grant, "the 5th CiCLE: Cyclic Innovation for Clinical Empowerment 2020"2020-08-07CoreTissue BioEngineering and Teijin Limited agree on alliance to mass produce artificial ligament2020-07-07The annual report of the AMED grant program was published2020-06-22CTBE conducted FDA Pre-Submission with the U.S, Food and Drug Administration (FDA) successfully. For Reference2020-06-18The CEO went onto the online platform of the Joint Pitch - Deep Tech for Good: Medical Innovations sponsored by SGInnovate (Singapore) and Japan Science and Technology Agency (JST)2020-02-12The 2020 renewal of the AMED grant program was approved2019-11-26The CEO went onto the platform of the 34th NEDO Pitch "Academic Venture x Health-tech"2019-11-18Received grant from the Ogasawara Foundation for the Promotion of Science & Engineering2019-10-16Funded as the first investment by Waseda University Official Fund
TOP